Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/19830
Title: | Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure | Authors: | VERBRUGGE, Frederik DUPONT, Matthias Finucan, Michael Gabi, Alaa Hawwa, Noel MULLENS, Wilfried Taylor, David O. Young, James B. Starling, Randall C. Tang, W. H. Wilson |
Issue Date: | 2015 | Publisher: | WILEY-BLACKWELL | Source: | EUROPEAN JOURNAL OF HEART FAILURE, 17 (9), p. 956-963 | Abstract: | Aims The aim of this study was to assess the haemodynamic response and tolerance to aggressive oral hydralazine/isosorbide dinitrate (HYD/ISDN) up-titration after intravenous vasodilator therapy in advanced decompensated heart failure (ADHF). Methods and results Medical records of 147 consecutive ADHF patients who underwent placement of a pulmonary artery catheter and received intravenous vasodilator therapy were reviewed. Intravenous sodium nitroprusside and sodium nitroglycerin as first-line agent for those with preserved blood pressures were utilized in 143 and 32 patients, respectively. Sixty-one percent of patients were converted to oral HYD/ISDN combination therapy through a standardized conversion protocol. These patients had a significantly higher admission mean pulmonary arterial wedge pressure compared with patients not converted (28 +/- 7 vs. 25 +/- 8 mmHg, respectively; P-value 0.024). Beneficial haemodynamic response to decongestive therapy, defined as low cardiac filling pressures and cardiac index >= 2.20 L/min/m(2) without emergent hypotension, was achieved in 32% and 29% of patients who did or did not receive oral HYD/ISDN, respectively (P-value 0.762). HYD/ISDN dosing was progressively and consistently decreased up to the moment of hospital discharge and during outpatient follow-up, primarily due to incident hypotension. Conclusion The use of a standardized haemodynamically guided up-titration protocol for conversion from intravenous to oral vasodilators may warrant subsequent dose reductions upon stabilization. | Notes: | [Verbrugge, Frederik H.; Dupont, Matthias; Mullens, Wilfried] Ziekenhuis Oost Limburg, Dept Cardiol, Genk, Belgium. [Verbrugge, Frederik H.; Mullens, Wilfried] Hasselt Univ, Doctoral Sch Med & Life Sci, Diepenbeek, Belgium. [Verbrugge, Frederik H.; Finucan, Michael; Gabi, Alaa; Hawwa, Noel; Taylor, David O.; Young, James B.; Starling, Randall C.; Tang, W. H. Wilson] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH USA. | Keywords: | haemodynamics; hydralazine; isosorbide dinitrate; systolic heart failure; vasodilator agents;Haemodynamics; Hydralazine; Isosorbide dinitrate; Systolic heart failure; Vasodilator agents | Document URI: | http://hdl.handle.net/1942/19830 | ISSN: | 1388-9842 | e-ISSN: | 1879-0844 | DOI: | 10.1002/ejhf.324 | ISI #: | 000363046600013 | Rights: | © 2015 The Authors European Journal of Heart Failure © 2015 European Society of Cardiology | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2016 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
verbrugge 1.pdf Restricted Access | Published version | 274.79 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
3
checked on Sep 5, 2020
WEB OF SCIENCETM
Citations
5
checked on Apr 22, 2024
Page view(s)
62
checked on Jul 22, 2022
Download(s)
48
checked on Jul 22, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.